AXGN
NASDAQ
Health Care
$39.85
USD
+$0.08 (+0.19%)
At close: Jul 17, 2026, 4:00 PM EDT
Market Cap:
$2.12B
Volume:
1.2M
Previous Close
$39.78
Day Range
$38.44 - $39.90
52 Week Range
$11.25 - $46.95
Average Volume (10 Days)
1.5M
P/E Ratio (TTM)
—
Dividend Yield
—
Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. The company is headquartered in Alachua, Florida and currently employs 622 full-time employees. The company offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel.
CEO
Mr. Michael Dale
Headquaters
Alachua, FLORIDA, US
Founded
1986
Employees
622
TMDX
Transmedics Group Inc
$73.98
-2.7%